SRx Health Solutions Inc. (SRXH)

SRx Health Solutions Inc. is a Canadian integrated healthcare services provider focused on specialty healthcare. They deliver customized solutions across all ten Canadian provinces, leveraging industry knowledge and technology to improve patient wellness.

47/100 AI Score MCap 7M Vol 84M

Company Overview

CEOKent Cunningham
Employees444
HeadquartersTampa, FL, US
IPO Year2010

SRx Health Solutions delivers comprehensive, integrated specialty healthcare services across Canada, leveraging technology and a patient-centric approach to enhance wellness. With a strong profit margin of 370.9% and a beta of 0.94, SRXH presents a unique opportunity in the Canadian healthcare market.

Investment Thesis

SRx Health Solutions presents a compelling investment opportunity due to its unique position in the Canadian specialty healthcare market. The company's integrated service model and patient-centric approach drive strong customer loyalty and consistent revenue streams. With a high profit margin of 370.9%, SRx demonstrates efficient operations and strong pricing power. Key growth catalysts include expanding service offerings and penetrating new geographic markets within Canada. The company's beta of 0.94 suggests relatively low volatility compared to the overall market. Investors should consider SRx for its potential to capitalize on the growing demand for specialized healthcare services in Canada. The company's focus on technology and innovation positions it well for long-term growth and value creation.

Key Highlights

  • Profit Margin of 370.9% indicates strong profitability and efficient cost management.
  • Gross Margin of 12.8% reflects the profitability of SRx's core services.
  • Beta of 0.94 suggests the stock is slightly less volatile than the market.
  • Integrated healthcare services provider operating across all ten Canadian provinces, ensuring broad market coverage.
  • Focus on specialty healthcare services, catering to a growing and specific market segment.

Competitors

Strengths

  • Integrated service model.
  • Patient-centric approach.
  • Strong profit margin (370.9%).
  • Established presence across Canada.

Weaknesses

  • Relatively low gross margin (12.8%).
  • Limited publicly available information.
  • Small market capitalization.

Catalysts

  • Upcoming: Expansion into new specialty healthcare areas, increasing service offerings to a broader patient base.
  • Ongoing: Continued integration of technology to improve service delivery and patient outcomes.
  • Ongoing: Strategic partnerships with healthcare providers to expand market reach.

Risks

  • Potential: Increased competition from larger, more established healthcare providers.
  • Potential: Changes in healthcare regulations impacting service delivery and reimbursement rates.
  • Potential: Economic downturn leading to reduced healthcare spending.
  • Ongoing: Dependence on key personnel and management team.

Growth Opportunities

  • Expansion of Service Offerings: SRx can expand its service offerings to include new specialty areas and innovative healthcare solutions. This would allow the company to attract a wider range of patients and increase revenue streams. The market for specialty healthcare services is growing rapidly, driven by the increasing prevalence of chronic diseases and the aging population. Timeline: Within the next 2-3 years.
  • Geographic Expansion within Canada: SRx can further penetrate existing markets and expand into new geographic areas within Canada. This would allow the company to reach more patients and increase its market share. The Canadian healthcare market is vast, with significant opportunities for growth in underserved areas. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: SRx can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This would allow the company to offer a more comprehensive range of services and strengthen its competitive position. The healthcare industry is consolidating, with many opportunities for strategic alliances. Timeline: Ongoing.
  • Technology Integration and Innovation: SRx can continue to invest in technology and innovation to improve its services and enhance patient outcomes. This would allow the company to differentiate itself from competitors and attract tech-savvy patients. The healthcare industry is rapidly adopting new technologies, such as telehealth and AI-powered diagnostics. Timeline: Ongoing.
  • Focus on Patient Engagement and Education: SRx can enhance its patient engagement and education programs to improve patient adherence and outcomes. This would lead to increased patient satisfaction and loyalty. Engaged and educated patients are more likely to follow treatment plans and achieve better health outcomes. Timeline: Ongoing.

Opportunities

  • Expansion of service offerings.
  • Geographic expansion within Canada.
  • Strategic partnerships and acquisitions.

Threats

  • Competition from larger healthcare providers.
  • Changes in healthcare regulations.
  • Economic downturn affecting healthcare spending.

Competitive Advantages

  • Integrated service model provides a competitive advantage.
  • Strong relationships with healthcare providers and payers.
  • Focus on patient-centric care fosters loyalty.
  • Established presence across all ten Canadian provinces.

About

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company was founded with the vision of providing comprehensive, patient-centric healthcare solutions across Canada. Over the years, SRx has evolved into a key player in the Canadian healthcare landscape, offering customized specialty healthcare services across all ten provinces. SRx combines deep industry knowledge, cutting-edge technology, and a strong patient focus to develop strategies and solutions aimed at improving the health and wellness of Canadians. Their services span a wide range of specialty areas, ensuring that patients receive the specific care they need. SRx differentiates itself through its integrated approach, which allows for seamless coordination of care and improved patient outcomes. The company's commitment to innovation and patient satisfaction has solidified its position as a trusted healthcare partner in Canada. SRx's headquarters are located in Tampa, US, and they employ 444 individuals.

What They Do

  • Provides integrated healthcare services.
  • Offers customized specialty healthcare solutions.
  • Operates across all ten Canadian provinces.
  • Focuses on improving patient wellness.
  • Combines industry knowledge with technology.
  • Delivers patient-centric care.

Business Model

  • Provides specialty healthcare services to patients across Canada.
  • Generates revenue through service fees and contracts with healthcare providers.
  • Focuses on integrated and customized solutions to improve patient outcomes.

Industry Context

SRx Health Solutions operates in the Canadian healthcare industry, which is characterized by increasing demand for specialized services and a growing aging population. The market is competitive, with players like AEON, BOLT, CLRB, GELS, and MRKR vying for market share. SRx differentiates itself through its integrated approach and patient-centric focus. The Canadian healthcare market is expected to continue growing, driven by factors such as technological advancements and increasing healthcare expenditure. SRx is well-positioned to capitalize on these trends, leveraging its expertise and established presence in the market.

Key Customers

  • Patients requiring specialized healthcare services.
  • Healthcare providers seeking integrated solutions.
  • Insurance companies and other payers.
AI Confidence: 71% Updated: 2/3/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2025 $7M $-964,000 $-0.07

Source: Company filings

Chart & Info

Price Chart

SRx Health Solutions Inc. (SRXH) stock price: $0.20 (-0.03, -14.50%)

Why Bull

  • Recent insider buying suggests confidence in SRXH's future prospects, indicating that leadership believes in the company's growth potential.
  • Community sentiment has shifted positively, with discussions highlighting SRXH's innovative healthcare solutions gaining traction in the market.
  • Analysts are optimistic about SRXH's strategic partnerships that enhance its service offerings and market reach.
  • The overall trend in the healthcare sector is leaning towards digital solutions, aligning well with SRXH's business model.

Why Bear

  • Despite recent positive sentiment, there are concerns about the competitive landscape in the healthcare sector, which could pressure SRXH's market share.
  • Some community members express skepticism about the sustainability of SRXH's growth, pointing to potential regulatory challenges ahead.
  • Recent discussions have highlighted supply chain issues that could impact SRXH's ability to deliver products consistently.
  • Market perception remains cautious due to broader economic uncertainties, which can affect investor confidence in healthcare stocks.

Latest News

Technical Analysis

RSI(14)
--
MACD
--
Volume
83,413,037

Rationale

AI-generated technical analysis for SRXH including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss SRx Health Solutions Inc. (SRXH) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for SRXH.

Make a Prediction

Set your price target for SRx Health Solutions Inc. (SRXH), choose a timeframe, and track your prediction accuracy.

Current price: $0.20

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SRXH.

Price Targets

Wall Street price target analysis for SRXH.

Insider Flow (30d)

No insider trades in the last 30 days.

MoonshotScore

46.5/100

Score Factors

  • Revenue Growth 5/100

    Revenue growth data is currently unavailable for this company.

  • Gross Margin 6/100

    Gross margin of 27.6% is acceptable but leaves limited room for R&D and marketing investment.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 5/100

    Cash position data is currently unavailable for this company.

  • R&D Intensity 5/100

    R&D spending data is currently unavailable for this company.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 5/100

    Float and volume data unavailable for liquidity analysis.

  • Price Momentum 0/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates SRXH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does SRx Health Solutions Inc. do?

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians. Their business model revolves around providing these specialized services directly to patients and partnering with other healthcare providers to enhance their service offerings.

Is SRXH stock a good buy?

SRXH stock presents a mixed investment profile. The company's high profit margin of 370.9% is a significant positive, indicating strong profitability. However, the low gross margin of 12.8% warrants further investigation. The company's focus on a growing specialty healthcare market in Canada is a potential growth driver. Investors should carefully consider the company's financial metrics, competitive landscape, and growth opportunities before making an investment decision. Further due diligence is recommended to assess the sustainability of the high profit margin and the potential for gross margin improvement.

What are the main risks for SRXH?

SRx Health Solutions faces several key risks. Increased competition from larger healthcare providers could erode market share. Changes in Canadian healthcare regulations could negatively impact service delivery and reimbursement rates. An economic downturn could lead to reduced healthcare spending, affecting revenue. The company's dependence on key personnel and management team poses a risk if there is turnover. These risks should be carefully considered by investors when evaluating SRXH.

Is SRXH a good stock to buy?

Whether SRXH is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.

What is the SRXH MoonshotScore?

The MoonshotScore for SRXH is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.

How often is SRXH data updated?

SRXH stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to SRXH is aggregated continuously from premium financial news sources throughout the day.

What are the growth catalysts for SRXH?

Growth catalysts for SRx Health Solutions Inc. (SRXH) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes SRx Health Solutions Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.

Who are SRXH's main competitors?

SRx Health Solutions Inc. (SRXH) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether SRXH has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.

What do analysts say about SRXH?

Wall Street analyst coverage for SRXH includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.

What is SRXH's market cap?

Market capitalization (market cap) for SRXH is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows SRXH's current market cap alongside enterprise value and other valuation metrics.

How has SRXH stock performed recently?

SRXH's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing SRXH's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.

What are the risks of investing in SRXH?

Key risk categories for SRXH include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures SRXH's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.

Are insiders buying or selling SRXH?

Insider trading activity for SRXH tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.

Is SRXH a good stock for beginners?

SRx Health Solutions Inc. (SRXH) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is SRXH for first-time investors?

Every stock carries risk, including SRx Health Solutions Inc. (SRXH). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like SRXH.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Financial data is based on limited publicly available information.
  • Analysis is based on current market conditions and may be subject to change.
Data Sources
profilefundamentalsexistingCopy